# FDA recall D-0139-2024

> **Padagis US LLC** · Class II · drug recall initiated 2023-11-01.

## Product

Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only, Manufactured By:  Sidmak Laboratories (India) Pvt. Ltd. Plot No. 20, Pharmacity, Selaqui Industrial Area, Dehradun-248 197 Uttarakhand, India Distributed By: Padagis, Allegan, MI 49010.  NDC: 0574-0118-30

## Reason for recall

Failed Tablets/Capsules specifications; missing/broken/extra tablets within the capsules

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0139-2024
- **Recalling firm:** Padagis US LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2023-11-01
- **Report date:** 2023-12-13

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Minneapolis, MN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0139-2024

## Citation

> AI Analytics. FDA recall D-0139-2024. Retrieved 2026-07-18 from https://api.ai-analytics.org/recall/D-0139-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*